Reviews citing this publication (2)
- Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development. Sasikumar PG, Ramachandra M. Front Immunol 13 752065 (2022)
- Developments in Carbohydrate-Based Metzincin Inhibitors. Cuffaro D, Nuti E, D'Andrea F, Rossello A. Pharmaceuticals (Basel) 13 E376 (2020)
Articles citing this publication (22)
- Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, Dufour A, Goebeler V, Kappelhoff R, Keller UAD, Klein T, Lange PF, Marino G, Morrison CJ, Prudova A, Rodriguez D, Starr AE, Wang Y, Overall CM. Matrix Biol 49 37-60 (2016)
- Preparation and Evaluation of Chitosan/PVA Based Hydrogel Films Loaded with Honey for Wound Healing Application. Chopra H, Bibi S, Kumar S, Khan MS, Kumar P, Singh I. Gels 8 111 (2022)
- kGCN: a graph-based deep learning framework for chemical structures. Kojima R, Ishida S, Ohta M, Iwata H, Honma T, Okuno Y. J Cheminform 12 32 (2020)
- Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors. Nuti E, Cuffaro D, D'Andrea F, Rosalia L, Tepshi L, Fabbi M, Carbotti G, Ferrini S, Santamaria S, Camodeca C, Ciccone L, Orlandini E, Nencetti S, Stura EA, Dive V, Rossello A. ChemMedChem 11 1626-1637 (2016)
- H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. Kim K, Shin Y, Kim J, Ulmer TS, An W. Epigenetics Chromatin 11 23 (2018)
- Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage. Kim Y, Kim J, Lee H, Shin WR, Lee S, Lee J, Park JI, Jhun BH, Kim YH, Yi SJ, Kim K. Int J Mol Sci 20 E4038 (2019)
- Optical imaging of MMP-12 active form in inflammation and aneurysm. Razavian M, Bordenave T, Georgiadis D, Beau F, Zhang J, Golestani R, Toczek J, Jung JJ, Ye Y, Kim HY, Han J, Dive V, Devel L, Sadeghi MM. Sci Rep 6 38345 (2016)
- Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms. Nuti E, Rossello A, Cuffaro D, Camodeca C, Van Bael J, van der Maat D, Martens E, Fiten P, Pereira RVS, Ugarte-Berzal E, Gouwy M, Opdenakker G, Vandooren J. Cells 9 E1634 (2020)
- Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products. Gao Q, Wang Y, Hou J, Yao Q, Zhang J. J Comput Aided Mol Des 31 625-641 (2017)
- A QSAR study on the inhibition mechanism of matrix metalloproteinase-12 by arylsulfone analogs based on molecular orbital calculations. Hitaoka S, Chuman H, Yoshizawa K. Org Biomol Chem 13 793-806 (2015)
- Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds. Rahman F, Nguyen TM, Adekoya OA, Campestre C, Tortorella P, Sylte I, Winberg JO. J Enzyme Inhib Med Chem 36 819-830 (2021)
- Multicomponent mixtures for cryoprotection and ligand solubilization. Ciccone L, Vera L, Tepshi L, Rosalia L, Rossello A, Stura EA. Biotechnol Rep (Amst) 7 120-127 (2015)
- The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases. Sylte I, Dawadi R, Malla N, von Hofsten S, Nguyen TM, Solli AI, Berg E, Adekoya OA, Svineng G, Winberg JO. PLoS One 13 e0200237 (2018)
- Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization. Nuti E, Rosalia L, Cuffaro D, Camodeca C, Giacomelli C, Da Pozzo E, Tuccinardi T, Costa B, Antoni C, Vera L, Ciccone L, Orlandini E, Nencetti S, Dive V, Martini C, Stura EA, Rossello A. ACS Med Chem Lett 8 293-298 (2017)
- Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy. Hermawan A, Putri H, Utomo RY. Daru 28 685-699 (2020)
- Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model. Devel L, Almer G, Cabella C, Beau F, Bernes M, Oliva P, Navarro F, Prassl R, Mangge H, Texier I. Molecules 24 E3499 (2019)
- Design, Synthesis, and Biological Evaluation of Tetrahydro-β-carboline Derivatives as Selective Sub-Nanomolar Gelatinase Inhibitors. Mangiatordi GF, Guzzo T, Rossano EC, Trisciuzzi D, Alberga D, Fasciglione G, Coletta M, Topai A, Nicolotti O. ChemMedChem 13 1343-1352 (2018)
- Ethyl gallate isolated from phenol-enriched fraction of Caesalpinia mimosoides Lam. Promotes cutaneous wound healing: a scientific validation through bioassay-guided fractionation. Bhat P, Patil VS, Anand A, Bijjaragi S, Hegde GR, Hegde HV, Roy S. Front Pharmacol 14 1214220 (2023)
- Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors. Cuffaro D, Camodeca C, Tuccinardi T, Ciccone L, Bartsch JW, Kellermann T, Cook L, Nuti E, Rossello A. ACS Med Chem Lett 12 1787-1793 (2021)
- Computer-Aided Screening and Revealing Action Mechanism of Food-Derived Tripeptides Intervention in Acute Colitis. Ge H, Zhang T, Tang Y, Zhang Y, Yu Y, Men F, Liu J, Yu Y. Int J Mol Sci 23 13471 (2022)
- Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening. Gimeno A, Cuffaro D, Nuti E, Ojeda-Montes MJ, Beltrán-Debón R, Mulero M, Rossello A, Pujadas G, Garcia-Vallvé S. Molecules 26 4553 (2021)
- Mechanistic insight into hydroxamate transfer reaction mimicking the inhibition of zinc-containing enzymes. Kwon N, Suh JM, Lim MH, Hirao H, Cho J. Chem Sci 11 9017-9021 (2020)
Related citations provided by authors (1)
- A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.. Rossello A, Nuti E, Catalani MP, Carelli P, Orlandini E, Rapposelli S, Tuccinardi T, Atkinson SJ, Murphy G, Balsamo A Bioorg Med Chem Lett 15 2311-4 (2005)